Diagnostic claims post-Mayo and Myriad: the pile-up begins

Author： Woessner Warren D   Chadwick Robin A  

Publisher： Future Science

ISSN： 2046-8954

Source： Pharmaceutical Patent Analyst, Vol.2, Iss.2, 2013-03, pp. : 165-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myriad Genetics

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 305-309

Informa Healthcare

Access to resources Recommend Favorite

Up-date on Diagnostic Strategies of Invasive Aspergillosis

By  

Current Pharmaceutical Design, Vol. 19, Iss. 20, 2013-06 ,pp. : 3595-3614

Bentham Science Publishers

Access to resources Recommend Favorite

-Blocker use up in elderly post AMI

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 290, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

It All Begins with One Case

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 4, 2010-12 ,pp. : 258-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Greece begins drug price cuts

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 612, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite